Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 24 11:27AM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-3.95 Insider Own6.67% Shs Outstand94.67M Perf Week-3.92%
Market Cap151.72M Forward P/E39.88 EPS next Y0.04 Insider Trans0.39% Shs Float88.78M Perf Month32.92%
Income-332.97M PEG- EPS next Q-0.01 Inst Own41.34% Short Float10.48% Perf Quarter75.37%
Sales142.05M P/S1.07 EPS this Y-115.91% Inst Trans11.52% Short Ratio8.18 Perf Half Y88.62%
Book/sh1.41 P/B1.13 EPS next Y145.71% ROA-95.65% Short Interest9.31M Perf Year-71.92%
Cash/sh0.85 P/C1.88 EPS next 5Y25.00% ROE-172.90% 52W Range0.73 - 5.78 Perf YTD49.07%
Dividend Est.- P/FCF4.48 EPS past 5Y- ROI-190.85% 52W High-72.40% Beta0.92
Dividend TTM- Quick Ratio1.45 Sales past 5Y-7.51% Gross Margin57.88% 52W Low117.78% ATR (14)0.12
Dividend Ex-Date- Current Ratio1.87 EPS Y/Y TTM-294.15% Oper. Margin-0.72% RSI (14)59.57 Volatility6.57% 9.04%
Employees53 Debt/Eq0.30 Sales Y/Y TTM-12.40% Profit Margin-234.40% Recom1.00 Target Price3.19
Option/ShortYes / Yes LT Debt/Eq0.30 EPS Q/Q30.45% Payout- Rel Volume0.64 Prev Close1.62
Sales Surprise10.74% EPS Surprise233.33% Sales Q/Q-23.59% EarningsMay 06 AMC Avg Volume1.14M Price1.60
SMA207.62% SMA5031.49% SMA20033.49% Trades Volume244,842 Change-1.54%
Date Action Analyst Rating Change Price Target Change
Jul-03-24Initiated H.C. Wainwright Buy $4
Nov-07-22Initiated Lake Street Buy $7
Nov-30-18Downgrade Mizuho Buy → Neutral
Today 09:00AM
Jul-09-24 04:30PM
Jun-11-24 10:50AM
Jun-06-24 04:05PM
Jun-05-24 08:30AM
07:00AM Loading…
May-29-24 07:00AM
May-17-24 09:15AM
May-16-24 09:16AM
May-13-24 05:52PM
May-10-24 03:12PM
May-07-24 10:28AM
May-06-24 08:59PM
05:46PM Loading…
Apr-25-24 08:00AM
Apr-03-24 08:00AM
Apr-01-24 09:00AM
Mar-12-24 11:11AM
Mar-11-24 04:26PM
Mar-04-24 05:07PM
Feb-29-24 04:05PM
Feb-28-24 10:15AM
Feb-26-24 07:57PM
11:30AM Loading…
Feb-23-24 11:30AM
Feb-22-24 12:35PM
Feb-19-24 12:39PM
Feb-16-24 12:41PM
Feb-13-24 05:45AM
Feb-12-24 10:30AM
Feb-09-24 02:51PM
Feb-05-24 03:56PM
Feb-02-24 12:32PM
Jan-29-24 12:30PM
Jan-26-24 09:15AM
Jan-24-24 06:54PM
Jan-22-24 03:42PM
Jan-19-24 09:36AM
Jan-17-24 10:15AM
Jan-15-24 03:29PM
Jan-10-24 10:45AM
Jan-08-24 12:14PM
Jan-05-24 06:56PM
Jan-04-24 09:46AM
Jan-03-24 08:59AM
Dec-25-23 02:06PM
Nov-14-23 08:00AM
Nov-10-23 01:11PM
Nov-09-23 08:49AM
Nov-08-23 06:46PM
Nov-02-23 12:06PM
Oct-06-23 04:30PM
Sep-22-23 08:38AM
Sep-14-23 01:12PM
Aug-28-23 06:30PM
Aug-25-23 04:05PM
Aug-23-23 08:48AM
Aug-08-23 04:45PM
Aug-06-23 08:05AM
Aug-03-23 04:29PM
Jul-31-23 07:27PM
Jul-27-23 04:01PM
Jul-24-23 08:30AM
Jul-19-23 07:38AM
Jul-07-23 09:16AM
Jun-26-23 07:00AM
Jun-16-23 06:30AM
May-26-23 12:06PM
May-10-23 06:12AM
May-09-23 07:28AM
May-05-23 08:00AM
May-04-23 10:54AM
Apr-27-23 09:00AM
Apr-25-23 01:03PM
Apr-24-23 09:00AM
Apr-17-23 06:43AM
Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vacirca Jeff LDirectorJun 11 '24Buy1.1110,00011,100151,159Jun 12 06:00 PM
Mason Heather LInterim Executive OfficerJun 05 '24Buy0.9725,00024,250212,650Jun 06 06:00 PM
Schlessinger SamSVP, General CounselMay 12 '24Option Exercise0.0038,0170138,895May 14 08:01 PM
Patel AjaySVP and CFOMay 12 '24Option Exercise0.0038,0170171,271May 14 08:00 PM
Schwichtenberg PaulSVP, CCOMay 12 '24Option Exercise0.0038,0170141,941May 14 08:01 PM
Tyree James LDirectorMar 14 '24Sale1.1210,25111,463188,251Mar 15 08:01 PM
Schlessinger SamSVP, General CounselFeb 21 '24Option Exercise0.0017,1510109,384Feb 23 05:32 PM
Patel AjaySVP and CFOFeb 21 '24Option Exercise0.0017,1510141,760Feb 23 05:30 PM
Schwichtenberg PaulSVP, CCOFeb 21 '24Option Exercise0.0017,1510112,430Feb 23 05:31 PM
Schlessinger SamSVP, General CounselFeb 11 '24Option Exercise0.0018,939098,785Feb 13 07:02 PM
Patel AjaySVP and CFOFeb 11 '24Option Exercise0.0047,3480140,991Feb 13 07:00 PM
Schwichtenberg PaulSee RemarksFeb 11 '24Option Exercise0.0047,3480111,661Feb 13 07:01 PM
Schlessinger SamSVP, General CounselOct 01 '23Option Exercise0.0019,404088,442Oct 03 07:27 PM
Peisert Daniel A.President & CEOSep 12 '23Sale2.9731,12192,432324,939Sep 13 08:15 PM
Peisert Daniel A.President & CEOSep 11 '23Sale3.04127,281386,972356,060Sep 13 08:15 PM
Schwichtenberg PaulSVP and CFOSep 11 '23Sale3.07104,980322,59364,313Sep 13 08:16 PM
Patel AjaySVP and CAOSep 11 '23Sale3.0464,313195,79493,643Sep 13 08:17 PM
Schlessinger SamSVP, General CounselSep 11 '23Sale3.0445,236137,44169,038Sep 13 08:18 PM
MCKEE WILLIAMDirectorAug 14 '23Sale3.1422,00069,045238,780Aug 15 06:00 PM
Schlessinger SamSVP, General CounselAug 05 '23Option Exercise0.007,1350117,434Aug 08 07:00 PM